Sign up for the Daily Newsletter, sent exclusively to our premium subscribers. We break down the big and messy topics of Asia’s tech and startup community. Get the newsletter in your inbox everyday with a premium subscription.
Hello reader,
Looking at today’s funding data took me by surprise because we have a whopping six companies in Asia that have gone through M&As in the past week. This is a massive jump from last week, where we had… none.
This is good news for the founders of most of these companies. After all, a great exit is the ultimate goal of every startup, and not everyone will make a grand public market debut like Grab and GoTo. For the majority of founders, an M&A is the most likely way they’ll make an exit – and get that happy ending to their entrepreneurial journey.
Cheers to them.
Image credit: Timmy Loen
You can find all other important investment deals that happened over the last few days in our weekly funding news wrap-up.
Let’s dive into the biggest deals and M&As that recently took place.
(P.S.: On that note, if you’re a founder curious about the M&A process, our CEO Willis Wee and COO Maria Li will be talking about Tech in Asia’s own road to getting acquired in our upcoming Founders Meetup: Singapore. Learn more about the event later in this newsletter.)
The biggest deals by country
🇨🇳 Viva Biotech Holdings, a China-based drug discovery platform, has bagged US$210 million from Highlight Capital and Temasek Holdings in a post-IPO fundraise.
🇮🇱 Israel-based AI startup AI21 Labs has raised US$53 million in a series C round.
🇮🇳 Travel fintech firm Scapia, which hails from India, has netted US$23 million in series A money from 3State Ventures and Elevation Capital.
M&As
Startups that are raising funds
Killer pitch decks
Join Tech in Asia’s 11th and final meetup of 2023!
Exclusive listicles
Thoughtful reads
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
